219 related articles for article (PubMed ID: 21151896)
21. Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.
Cassidy RJ; Zhang X; Patel PR; Shelton JW; Escott CE; Sica GL; Rossi MR; Hill CE; Steuer CE; Pillai RN; Ramalingam SS; Owonikoko TK; Behera M; Force SD; Fernandez FG; Curran WJ; Higgins KA
Cancer; 2017 Oct; 123(19):3681-3690. PubMed ID: 28608966
[TBL] [Abstract][Full Text] [Related]
22. DNA sequence copy number aberrations associated with histological subtypes and DNA ploidy in gastric carcinoma.
Kong G; Oga A; Park CK; Kawauchi S; Furuya T; Sasaki K
Jpn J Cancer Res; 2001 Jul; 92(7):740-7. PubMed ID: 11473724
[TBL] [Abstract][Full Text] [Related]
23. EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.
Varella-Garcia M; Mitsudomi T; Yatabe Y; Kosaka T; Nakajima E; Xavier AC; Skokan M; Zeng C; Franklin WA; Bunn PA; Hirsch FR
J Thorac Oncol; 2009 Mar; 4(3):318-25. PubMed ID: 19247083
[TBL] [Abstract][Full Text] [Related]
24. High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma.
Bernheim A; Toujani S; Saulnier P; Robert T; Casiraghi O; Validire P; Temam S; Menard P; Dessen P; Fouret P
Lab Invest; 2008 May; 88(5):464-73. PubMed ID: 18332873
[TBL] [Abstract][Full Text] [Related]
25. EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.
Arifin M; Hiyama K; Tanimoto K; Wiyono WH; Hiyama E; Nishiyama M
Oncol Rep; 2007 Jun; 17(6):1405-11. PubMed ID: 17487398
[TBL] [Abstract][Full Text] [Related]
26. High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines.
Zhu H; Lam DC; Han KC; Tin VP; Suen WS; Wang E; Lam WK; Cai WW; Chung LP; Wong MP
Cancer Lett; 2007 Jan; 245(1-2):303-14. PubMed ID: 16517066
[TBL] [Abstract][Full Text] [Related]
27. Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers.
Tessema M; Rossi MR; Picchi MA; Yingling CM; Lin Y; Ramalingam SS; Belinsky SA
Lung Cancer; 2018 Sep; 123():99-106. PubMed ID: 30089603
[TBL] [Abstract][Full Text] [Related]
28. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
[TBL] [Abstract][Full Text] [Related]
29. Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.
Sholl LM; Yeap BY; Iafrate AJ; Holmes-Tisch AJ; Chou YP; Wu MT; Goan YG; Su L; Benedettini E; Yu J; Loda M; Jänne PA; Christiani DC; Chirieac LR
Cancer Res; 2009 Nov; 69(21):8341-8. PubMed ID: 19826035
[TBL] [Abstract][Full Text] [Related]
30. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
Han JY; Kim SH; Lee YS; Lee SY; Hwang JA; Kim JY; Yoon SJ; Lee GK
Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
[TBL] [Abstract][Full Text] [Related]
31. EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients.
Yang SY; Yang TY; Li YJ; Chen KC; Liao KM; Hsu KH; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Shen CY; Chang GC; Yang PC; Chen CJ
Int J Cancer; 2013 Jan; 132(2):449-58. PubMed ID: 22573488
[TBL] [Abstract][Full Text] [Related]
32. Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas.
Choi JS; Zheng LT; Ha E; Lim YJ; Kim YH; Wang YP; Lim Y
Lung; 2006; 184(6):355-62. PubMed ID: 17086460
[TBL] [Abstract][Full Text] [Related]
33. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of epidermal growth factor receptor gene status in lung adenocarcinoma.
Li C; Sun Y; Fang Z; Han X; Fang R; Zhang Y; Pan Y; Zhang W; Ren Y; Ji H; Chen H
J Thorac Oncol; 2011 Jun; 6(6):1016-21. PubMed ID: 21532505
[TBL] [Abstract][Full Text] [Related]
35. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.
Shen H; Gao W; Wu YJ; Qiu HR; Shu YQ
Biomed Pharmacother; 2009 Jul; 63(6):396-403. PubMed ID: 18848758
[TBL] [Abstract][Full Text] [Related]
36. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis.
Boelens MC; Kok K; van der Vlies P; van der Vries G; Sietsma H; Timens W; Postma DS; Groen HJ; van den Berg A
Lung Cancer; 2009 Dec; 66(3):372-8. PubMed ID: 19324446
[TBL] [Abstract][Full Text] [Related]
37. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
Chiang DY; Villanueva A; Hoshida Y; Peix J; Newell P; Minguez B; LeBlanc AC; Donovan DJ; Thung SN; Solé M; Tovar V; Alsinet C; Ramos AH; Barretina J; Roayaie S; Schwartz M; Waxman S; Bruix J; Mazzaferro V; Ligon AH; Najfeld V; Friedman SL; Sellers WR; Meyerson M; Llovet JM
Cancer Res; 2008 Aug; 68(16):6779-88. PubMed ID: 18701503
[TBL] [Abstract][Full Text] [Related]
38. HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Uehara T; Fujimoto M; Tsuruyama T; Date H; Haga H
Lung Cancer; 2014 Sep; 85(3):373-8. PubMed ID: 25047676
[TBL] [Abstract][Full Text] [Related]
39. EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma.
Colombino M; Paliogiannis P; Cossu A; Santeufemia DA; ; Sini MC; Casula M; Palomba G; Manca A; Pisano M; Doneddu V; Palmieri G
BMC Pulm Med; 2019 Nov; 19(1):209. PubMed ID: 31711449
[TBL] [Abstract][Full Text] [Related]
40. Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.
Jiang F; Yin Z; Caraway NP; Li R; Katz RL
Neoplasia; 2004; 6(5):623-35. PubMed ID: 15548372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
